Literature DB >> 20802415

The sequence polymorphism of MnSOD gene in subjects with respiratory insufficiency in COPD.

Tadeusz Pietras1, Janusz Szemraj, Andrzej Witusik, Monika Hołub, Michał Panek, Radosław Wujcik, Paweł Górski.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with the development of respiratory failure, which, in turn, exposes the tissues to oxidative stress, which is both a cause and a result of respiratory insufficiency. The first-line defense against oxidative stress is provided by the mitochondrial enzyme manganese superoxide dismutase (MnSOD), which is a superoxide anion scavenger. It is unknown whether genetic variability of the enzymes protecting against reactive oxygen species (ROS) can influence the development of respiratory failure in COPD patients. The aim of the study was to determine the correlation between polymorphism of MnSOD signal peptide and the occurrence of respiratory failure in the course of COPD. MATERIAL/
METHODS: The study group consisted of 162 COPD patients (113 men and 49 women). The control group consisted of 63 subjects. Respiratory failure was diagnosed in 42 COPD patients. In all the examined subjects, the polymorphism resulting in alanine at residue 9 being replaced by valine and the expression of MnSOD in blood cells were determined.
RESULTS: The Val/Val phenotype was demonstrated to occur in COPD patients more frequently than in the control group, as well as being associated with a lower expression level of MnSOD mRNA. Respiratory failure in the course of COPD also correlates with lower expression of MnSOD mRNA.
CONCLUSIONS: The presence of valine at position 9 of the MnSOD signal peptide encoded by exon 2 is a risk factor for the occurrence of respiratory failure in the course of COPD in the Polish population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802415

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

Review 1.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

2.  Changes in chemiluminescence of whole blood of COPD patients treated with Hypoxen and effects of C₆₀ fullerenes on blood chemiluminescence.

Authors:  Kirill N Novikov; Nadezhda G Berdnikova; Alexey K Novikov; Oksana Y Lyusina; Olga G Muhitova; Olga I Yablonskaya; Ha Do Minh; Vladimir L Voeikov
Journal:  Med Sci Monit       Date:  2012-02

3.  Concentration of angiopoietins 1 and 2 and their receptor Tie-2 in peripheral blood in patients with chronic obstructive pulmonary disease.

Authors:  Dorota Kierszniewska-Stępień; Tadeusz Pietras; Maciej Ciebiada; Paweł Górski; Henryk Stępień
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

4.  Oxidants in Acute and Chronic Lung Disease.

Authors:  Praveen Mannam; Anup Srivastava; Jaya Prakash Sugunaraj; Patty J Lee; Maor Sauler
Journal:  J Blood Lymph       Date:  2014

Review 5.  Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.

Authors:  Hamad Ghaleb Dailah
Journal:  Molecules       Date:  2022-08-28       Impact factor: 4.927

6.  Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium.

Authors:  S Blein; S Berndt; A D Joshi; D Campa; R G Ziegler; E Riboli; D G Cox
Journal:  Free Radic Res       Date:  2014-01-23

7.  Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.

Authors:  Yiming Du; Yuwen Xue; Wei Xiao
Journal:  Med Sci Monit       Date:  2016-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.